Sirius Pharmaceuticals Private Limited, a active private limited company, was established on 09 October 1991 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24239MH1991PTC063523. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Ajay Amerlal Melwani (Director), Ayush Ajay Melwani (Director). Past directors included Anju Ajay Melwani, Ayush Ajay Melwani, Neeraj Maniyar. It holds no open charges and ₹3.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 301, Sainara, 21, North Avenue, N. Linking Road Junction, Santacruz (W),, Mumbai, Maharashtra, 400054.
U24239MH1991PTC063523
063523
09 October 1991
₹5.00 M
₹0.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Sirius Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ajay Amerlal Melwani | Director | 09 Oct 1991 | Current |
| Ayush Ajay Melwani | Director | 07 Sep 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Nov 2014 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Director | 09 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sirius Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 14.39% decrease. The company also saw a substantial fall in profitability, with a 15.65% decrease in profit. The company's net worth moved up by a moderate rise of 6.83%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Sirius Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹30,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jan 2006 | Hdfc Bank Limited | ₹3.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sirius Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sirius Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sirius Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Sirius Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Sirius Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Progress on Ayush Ajay Melwani was appointed as a Director was appointed as a Director on 07 Sep 2018 & has been associated with this company since 7 years 2 months . was documented.
A charge registered on 09 Jan 2006 via Charge ID 80003644 with Hdfc Bank Limited was fully satisfied on 22 Mar 2016. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited of Rs. 30.00 M registered on 09 Jan 2006 with Charge ID 80003644 was modified on 22 May 2006. was documented.
A charge with Hdfc Bank Limited amounted to Rs. 30.00 M with Charge ID 80003644 was registered on 09 Jan 2006. was recorded as a recent event.
The CIN of Sirius Pharmaceuticals Private Limited is U24239MH1991PTC063523.
Sirius Pharmaceuticals Private Limited is headquartered at 301, Sainara, 21, North Avenue, N. Linking Road Junction, Santacruz (W),, Mumbai, Maharashtra, 400054.
Sirius Pharmaceuticals Private Limited was incorporated on 09 October 1991.
The current directors of Sirius Pharmaceuticals Private Limited are
The primary industry of Sirius Pharmaceuticals Private Limited is Trade.
Sirius Pharmaceuticals Private Limited is unlisted.
The authorized capital of Sirius Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹0.50 M.
The compliance status of Sirius Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX